Q_A_RFP_75N95024R00054_0002.pdf

67 KB Posted

Attached to
PSPP RFP
Solicitation number
75N95024R00054
Issued by

About this file

Written by GovTribe AI ·

This document is a set of Questions and Answers (Q&A) related to Request for Proposal (RFP) No. 75N95024R00054 for the NINDS Preclinical Screening Platform for Pain (PSPP) contract opportunity.

The key details are:

  • The RFP seeks to establish a preclinical screening platform for pain research.
  • The Q&A addresses several technical and administrative questions, including whether non-rodent work is required, which asset numbers to use, if travel to conferences can be budgeted, who can submit the proposal via the NIH eCPS system, and clarification on the required representations and certifications.
  • The RFP is being issued by the Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse.
  • While some issues were addressed in a previous amendment, this Q&A document provides additional clarification on outstanding questions from potential offerors.

View the file

Other files

File Type Posted
Sol_75N95024R00054_Amd_0002.pdf PDF
A8_-_Additional_Technical_Proposal_Instructions_(amended)_0001.pdf PDF
Sol_75N95024R00054_Amd_0001.pdf PDF
A20_-_Sample_TO1_SOW_(amended)_0001.pdf PDF
Breakdown_of_Proposed_Estimated_Costs.xlsx XLSX spreadsheet
Additional_Technical_Proposal_Instructions.pdf PDF
Points-of-contact.pdf PDF
A19_-_DEC_Acknowledgment.pdf PDF
Nondisclosure.pdf PDF
SuitabilityRoster.xlsx XLSX spreadsheet
Section_K.docx DOCX document
NIDA_Supplemental_Invoice_Instructions.pdf PDF
A1_-_Packaging_and_Delivery_of_Proposals_for_Use_with_the_NIH_eCPS_website.pdf PDF
VAS_Worksheet.pdf PDF
Disclosure_of_Lobbying.pdf PDF
Emp-sep-checklist.pdf PDF
A20_Sample_TO1_SOW_4-30-2024_final.pdf PDF
Sol_75N95024R00054.pdf PDF
Wage_Rate_Deter.pdf PDF
A21_RFP_Cover_Letter_4-30-2024_s.pdf PDF
Tech-Prop-Cost-Summ.pdf PDF
Summary-related-activities.pdf PDF
NIH(RC)-1.pdf PDF
Proposal_Intent_Response_Form.pdf PDF
SOW_2-08-2024_final.pdf PDF
NIH2043.pdf PDF
Show all 26

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

Vendor Questions for RFP No. 75N95024R00054 - NINDS Preclinical Screening Platform for Pain (PSPP)

1. In the SOW Performance Area1 under technical requirements there is reference for non-rodent work under C. Is this required or optional? They should provide their best response as to what is feasible from their expertise (as of now, currently, we do not/have not required to go to non-rodents. We cannot predict what may be needed in the future).

2. In terms asset number for the various tests there are recommendations in the SOW and a separate recommendation under Additional technical proposal instructions.

The numbers do not match in the 2 documents so we were wondering which we should consider. (This issue was addressed in Amendment 1).

3. Can we budget travel to main conferences where we present PSPP related research

(examples are SFN, IASP and ACNP conferences)? (This will depend on contract office and the contractor making a request? In the ongoing contract we had not paid for travel, but they have asked)

4. Does the submission via NIH eCPS need to be done by a particular individual?

Submission can be made by any authorized employee within an offeror’s organization with an eCPS account.

5. Section K- Representations, Certifications, and Other Statements of Offerors.

Clarification needed, if we are registered in SAM.gov does that essentially provide you with confirmation the certifications have been approved?

The completed Section K document must be included with all offerors’ business proposals even if they are actively registered in SAM.gov.

https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttp-3A__SAM.gov%26d%3DDwQFAg%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DVVHKRiiIrBO1k50aqpwcJqrHPYHqG7Twee497qKLpF3L7Vil2UgFqxrGSz3q5XIN%26m%3DYenMQeVadYT8vnJz2diBiqZRup9-u3_aH2ij7PiozfHFd2tkNLT1e3EZpPb5NOvR%26s%3DdrUpkVHhfyamaPqv1tpiFTWqA8QVYypepM6ejf3ldLk%26e%3D&data=05%7C02%7Cevan.feely%40nih.gov%7Ca40a762dabf7449dc5d008dc7110aa0a%7C14b77578977342d58507251ca2dc2b06%7C0%7C0%7C638509563588318455%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=4PEKISmFd3bBNWRttmu4ItoI0yBnM3t%2BTwKzIoV8l7M%3D&reserved=0 https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttp-3A__SAM.gov%26d%3DDwQFAg%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DVVHKRiiIrBO1k50aqpwcJqrHPYHqG7Twee497qKLpF3L7Vil2UgFqxrGSz3q5XIN%26m%3DYenMQeVadYT8vnJz2diBiqZRup9-u3_aH2ij7PiozfHFd2tkNLT1e3EZpPb5NOvR%26s%3DdrUpkVHhfyamaPqv1tpiFTWqA8QVYypepM6ejf3ldLk%26e%3D&data=05%7C02%7Cevan.feely%40nih.gov%7Ca40a762dabf7449dc5d008dc7110aa0a%7C14b77578977342d58507251ca2dc2b06%7C0%7C0%7C638509563588329454%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=cZDyN%2B7e0mT56%2BRQMPWjacgd5JjLuQk0Gi5Q75x0GG4%3D&reserved=0

File details come from the government source that posted it. Updated .